Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It seems like you have a good plan. I just started a couple of months ago. Normally I play big promo like LEXG and ALZM but i'm looking for different play. But i do have the same problem as you.... i hold to long and pray
During the past couple of weeks i've been following some good people like yourself....stalk....lol on ihub
So who is good to follow on ihub or that one person ...hope it's not HDOGTX....lol
i could understand if you don't wanna tell me.
but i will be following your rabbit trail>>>>>
Thanks for alway writin back!!!
homdance!
What's the target price?
You are the Biotech Rabbit Queen!
kei are you in ACOR?
NICE!!! FCSC is the real deal!
20K and 30K buys!!! .965x.975!!! Break da dollar!!!
penny stocks $LFVN=======>IS A NO BRAINER!!!! on PBS NBC ABC primetime
on ABC PRIMTIME NBC and PBS!!!!!
on ABC PRIMTIME NBC and PBS!!!!!
Check out penny stocks $LFVN on ABC primetime http://www.mylifevantage.com/warner/default.aspx THIS IS ((((BIG)))) take the pill!!!!
*LifeVantage Corp. Announces Q3 Preliminary Net Revenue Of Approx. $10 Mln
They are also getting paid 4,000 to post it but also http://brokerz.com/tag/rumor/ posted it on their site.... gonna be on fire..............=============>to the dollar!
at .30x.50 this can fly pass a dollar very quick!
KEI....
I missed the boat on this one..............i might buy on the dip!
oh....yeah i'm not a dancing girl i'm a dancing man.......just like the pic......
how huge?
Jersey boy to Jersey Boy why would waste blogging about a stock I don't have. I was as lucky as you buying on the f@&$!ng DIP.
Nice Kei!!!
do you know anything about VPRO?
wow bigg pull!!!!
I meant the same promo as ALZM....check the board promo link there! glty
Next LEXG
is this the BDPS.........lol
Is this a pre pump?
Great call on ELTP!!!!
What is SDAD really worth?
What do you thing ELTP is worth?
This is GREAT!
Starting to build again!
LFVN lines just cross will break res at .90
ADXS up 14% Target Price .50
Advaxis Inc. (OTCBB: ADXS), a development-stage biotechnology company focused on therapeutic cancer vaccines that utilize multiple mechanisms of immunity, similar to companies like Dendreon Corporation (Nasdaq: DNDN) and Exelixis, Inc. (Nasdaq: EXEL), was initiated with an Outperform rating by Zacks Research, according to a recent press release.
We are initiating coverage of Advaxis Inc. (ADXS) with an Outperform rating. Our twelve-month price target is $0.50.
Advaxis (ADXS) is a development stage biotechnology company focused on the research, development and commercialization of safe and effective therapeutic cancer vaccines that utilize multiple mechanisms of immunity.
The Company is developing a live, attenuated Listeria vaccine technology under license from the University of Pennsylvania which secretes a protein sequence containing a tumor-specific antigen. This vaccine technology is capable of stimulating the body’s immune system to process and recognize the antigen as if it were foreign, generating an immune response able to attack the cancer. This is a broadly enabling platform technology that can be applied to the treatment of many types of cancers, infectious diseases and auto-immune disorders.
This technology involves the creation of genetically engineered Listeria that stimulates the immune system to induce antigen-specific anti-tumor immune response involving both innate and adaptive arms of the immune system. In addition, this technology facilitates the immune response by altering tumors to make them more susceptible to immune attack, and increasing the number and maturation of development of specific cells that underlie a strong therapeutic immune response.
The Listeria platform technology is unique and holds advantages over its peers in three ways.
Advaxis’ Listeria-based cancer vaccine can deliver bioengineered cancer antigen fused with a unique, proprietary strong adjuvant LLO which elicits both innate and adaptive immune systems in the body to fight cancer. The immune response elicited by Advaxis’ cancer vaccines has been the most comprehensive and robust so far in the industry.
Advaxis’ cancer vaccines can reduce the amount of regulatory T cells and myeloid suppressor cells which help protect tumors from attacking by cytotoxic T cells.
Another distinctive feature of Advaxis’ cancer vaccines is their ability to change the ratio between killer T-cells and regulatory T cells (the Kill Ratio) inside the tumor from 1:1.3 to 22.7:1.
Based on its proprietary Listeria technology, Advaxis has established a pipeline targeting various cancer indications. The Company’s lead candidate is ADXS11-001. Pre-clinical and Phase I clinical trials have demonstrated that ADXS11-001 is well tolerated and has shown impressive efficacy in cervical cancer patients.
ADXS11-001 is currently under two Phase II clinical trials for the treatment of cervical cancer and cervical dysplasia respectively. Another two Phase II trials for the treatment of cervical cancer and head and neck cancer are planned to initiate in 2Q2011.
The Company’s early stage candidates include ADXS31-142 for prostate cancer and ADXS31-146 for breast and brain cancer as well as canine osteosarcoma. Phase I trials for these two candidates will be conducted if funds are available.
We believe Advaxis’ Listeria technology is a viable drug delivery system which targets the rather large cancer market. The Company’s shares are undervalued in our view. Risk is higher though at this point, return should be also high if any progress can be made in advancing its pipeline.
Risks include cash burn concern, early to middle stage development risk, and over-the-counter market trading.
For a free copy of the full research report, please email scr@zacks.com with ADXS as the subject.
Follow Zacks Small Cap Research on Twitter at Twitter.com/ZacksSmallCap
Zacks Investment Research
CONTACT: 888-288-5215 · Please read our Full Disclaimer pertaining to this article.
Re: looks good whats the catalsyt here ..............Steady UP TICK no selli...
I like this one!!!
Yupppp
They bought early maybe in the .002's then sold half when it went to .01 to collect some profits........
So the other half is considered free shares!
barchart strong buy!
http://www.barchart.com/opinions/stocks/LFVN
my scanner picked this up yesterday.........dunno why i'm still in!
Dog Stock what the hell was I thinking?
Great email.........do you think it will work?
Xbigshot1
Nice to see you here. Great videos!
Why are people selling this can go to .10!
Get it when it dips!
It all depends on how much you put in and how much you wanna make.
I got in a 1.16 but got out during the shake. I made some money but like i said all party have to go nite nite..........if it crashes it will crash hard! But it's up to you lots of good plays out there LEXG is not the only one.